Gw&K Investment Management, LLC Biocryst Pharmaceuticals Inc Transaction History
Gw&K Investment Management, LLC
- $11.8 Billion
- Q4 2024
A detailed history of Gw&K Investment Management, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 2,941,396 shares of BCRX stock, worth $24.4 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
2,941,396
Previous 3,277,600
10.26%
Holding current value
$24.4 Million
Previous $24.9 Million
11.2%
% of portfolio
0.19%
Previous 0.21%
Shares
10 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
167MCall Options Held
728KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.9MShares$181 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$165 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$98.2 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$75.2 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$67.4 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.54B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...